Tecan Group AG · SIX:TECN

Tecan — H1 2013 Earnings Presentation

23 slides from Tecan's earnings presentation, Aug 14, 2013

  1. Slide 1: Half Year Results 2013

    Zürich, August 14th 2013 Half Year Results 2013 Analyst & Media Conference Call

  2. Slide 2: Speakers

    Speakers Dr. David Martyr, CEO Dr. Rudolf Eugster, CFO

  3. Slide 3: Agenda

    Tecan Half Year Results 2013 / August 14th 2013 / p3 Agenda • Introduction Dr. David Martyr • Financial Results Dr. Rudolf Eugster • Priorities & Outlook Dr. David Martyr • Questions & Answers

  4. Slide 4: H1 2013 Performance

    Tecan Half Year Results 2013 / August 14th 2013 / p4 H1 2013 Performance • Stable sales in tough market environment • As anticipated, Q1 was difficult; austerity measures unsettled the markets • Positive trend in Q2 with double-digit sales growth • Continued significant growth in China, Components a

  5. Slide 5: Agenda

    Tecan Half Year Results 2013 / August 14th 2013 / p5 Agenda • Introduction Dr. David Martyr • Financial Results Dr. Rudolf Eugster • Priorities & Outlook Dr. David Martyr • Questions & Answers

  6. Slide 6: H1 2013 Sales Performance and Order Entry

    Tecan Half Year Results 2013 / August 14th 2013 / p6 H1 2013 Sales Performance and Order Entry Sales 200 182.2 181.8 180 160 • Sales H1 2013 vs. H1 2012 140 120 • -0.2% in Swiss Francs 100 80 • -0.5% in local currencies 60 CHF (mio) 40 • Significant decline in Q1 and double- 20 0 digit sales growth

  7. Slide 7: H1 2013 Segment Sales

    Tecan Half Year Results 2013 / August 14th 2013 / p7 H1 2013 Segment Sales Sales (in CHF millions) 120.0 • Life Sciences Business: 100.8 97.6 • Sales 3.2% below prior-year in CHF and 100.0 81.4 84.2 3.5% in local currencies 80.0 • Affected by austerity measures and budget 2012 cuts in Europe and Nor

  8. Slide 8: H1 2013 Regional Sales Development

    Tecan Half Year Results 2013 / August 14th 2013 / p8 H1 2013 Regional Sales Development YoY % -0.1% in LC • Europe: decrease is primarily the result YoY % YoY % of lower sales in the Life Sciences +1.7% in CHF +6.4% in LC +0.9% in LC Business due to the continuing tough +2.5% in CHF Others +1.6% in

  9. Slide 9: H1 2013 Gross Profit

    Tecan Half Year Results 2013 / August 14th 2013 / p9 H1 2013 Gross Profit Gross Profit (% = as a % of sales) • Gross profit amounted to CHF 88.6m • CHF 1.9m or 2.1% below H1 2012 100 90.5 88.6 90 80 70 • Slight reduction in gross profit margin 60 • Product mix impact: 48.8 % 49.7 % CHF (mio) 50 more

  10. Slide 10: H1 2013 Cost Structure

    Tecan Half Year Results 2013 / August 14th 2013 / p10 H1 2013 Cost Structure Operating Expenses (% = as a % of sales) • Costs decreased by CHF 2.5m (-3.7%) • Selling & Marketing 80 • About stable 68.3m 65.8m (37.4%) (36.2%) • Reduction on Corporate level and increased investments in sales organizati

  11. Slide 11: H1 2013 EBIT

    Tecan Half Year Results 2013 / August 14th 2013 / p11 H1 2013 EBIT EBIT (% = as a % of sales) • EBIT reached CHF 23.1m • CHF 0.7m or 3.3% above H1 2012 25.0 23.1 22.4 • EBIT margin increased to 12.7% 20.0 • Effects impacting the EBIT margin: 15.0 - GP margin 90 bps lower (-) 12.7 % 12.3 % CHF (mio)

  12. Slide 12: H1 2013 Segment Profitability

    Tecan Half Year Results 2013 / August 14th 2013 / p12 H1 2013 Segment Profitability EBIT (in CHF millions) 30.0 25.0 25.0 21.4 • Life Sciences Business: 20.0 • EBIT and EBIT margin declined as a result of 2012 lower sales 15.0 2013 10.0 • Segment generates majority of EBIT in 4.8 second half year 5.

  13. Slide 13: H1 2013 Net Profit

    Tecan Half Year Results 2013 / August 14th 2013 / p13 H1 2013 Net Profit Net Profit (% = as a % of sales) • Net profit of CHF 16.5m • Decrease due to lower financial result 20 17.7 attributable to currency hedging 16.5 measures 15 • Net profit margin reached 9.1% 9.7 % 9.1% 10 (H1 2012: 9.7 %) CHF (

  14. Slide 14: H1 2013 Basic Earnings per Share

    Tecan Half Year Results 2013 / August 14th 2013 / p14 H1 2013 Basic Earnings per Share Basic Earnings per Share • Earnings per share of CHF 1.51 2 1.64 1.51 • Number of shares outstanding: 1.5 11.0m (June 30, 2012: 10.9m) CHF / share 1 0.5 0 2012 2013

  15. Slide 15: H1 2013 Cash Flow

    Tecan Half Year Results 2013 / August 14th 2013 / p15 H1 2013 Cash Flow 200000 160000 144.5m +28.4m -22.9m 137.7m from Operations prefinancing -6.9m -5.4m 120000 excl. prefinancing of OEM from Investments from 80000 development Financing1 Cash at end Cash at end 40000 of 2012 of H1 2013 0 • Cash flo

  16. Slide 16: H1 2013 Key Figures

    Tecan Half Year Results 2013 / August 14th 2013 / p16 H1 2013 Key Figures CHF m 2012 2013 Δ 12/13 Sales 182.2 181.8 -0.2% Gross Profit 90.5 88.6 -2.1% in % of sales 49.7% 48.8% R&D 22.5 21.3 -5.1% in % of sales 12.3% 11.7% OPEX 68.3 65.8 -3.7% in % of sales 37.4% 36.2% Operating profit / EBIT 22.4 2

  17. Slide 17: Agenda

    Tecan Half Year Results 2013 / August 14th 2013 / p17 Agenda • Introduction Dr. David Martyr • Financial Results Dr. Rudolf Eugster • Priorities & Outlook Dr. David Martyr • Questions & Answers

  18. Slide 18: Priorities 2013

    Tecan Half Year Results 2013 / August 14th 2013 / p18 Priorities 2013 Commence instrument • Development successfully completed shipments for Dako Omnis (P16) • First instruments for market launch delivered in June • Assay integration successfully completed, Commence instrument validation & verificat

  19. Slide 19: 2013: Key Challenges and Positive Performance Drivers

    Tecan Half Year Results 2013 / August 14th 2013 / p19 2013: Key Challenges and Positive Performance Drivers • Overall, challenges and growth drivers played out about as expected • Individually, some were more pronounced than anticipated Key Positive Performance Challenges Drivers • Challenging econo

  20. Slide 20: Outlook for 2013 Confirmed

    Tecan Half Year Results 2013 / August 14th 2013 / p20 Outlook for 2013 Confirmed Sales Mid-single-digit sales growth in local currencies Profitability EBIT Margin to grow around 50 bps Based on average FX rates of: 1.21 EUR/CHF and 0.92 USD/CHF

  21. Slide 21: Agenda

    Tecan Half Year Results 2013 / August 14th 2013 / p21 Agenda • Introduction Dr. David Martyr • Financial Results Dr. Rudolf Eugster • Priorities & Outlook Dr. David Martyr • Questions & Answers

  22. Slide 22: Next Events and Contact

    Tecan Half Year Results 2013 / August 14th 2013 / p22 Next Events 2013: September 11: Capital Markets Day 2014: March 11: Financial Results 2013 April 16: Annual Shareholder Meeting Contact Martin Braendle Head of Corporate Communications & Investor Relations Phone: +41 (0) 44 922 84 30 investor@tec

  23. Slide 23: Safe Harbor Statement

    Safe Harbor Statement All statements in this presentation not referring to historical facts are predictions of the future and constitute no guarantee whatsoever of future performances. They are subject to risks and uncertainties including, but not limited to, future global economic conditions, excha

Tecan Group — H1 2013 Earnings Presentation on 6ix